Cancer Gene Screens Save Money, Not Lives (CME/CE)
(MedPage Today) — Screening patients with metastatic colorectal cancer for mutations in the KRAS and BRAF genes before starting targeted drug therapy saves costs, but does not improve survival chances, researchers said.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com